These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 9712341)

  • 1. Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus.
    Mackness B; Mackness MI; Arrol S; Turkie W; Julier K; Abuasha B; Miller JE; Boulton AJ; Durrington PN
    Atherosclerosis; 1998 Aug; 139(2):341-9. PubMed ID: 9712341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
    Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
    Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus.
    Agachan B; Yilmaz H; Karaali Z; Isbir T
    Cell Biochem Funct; 2004; 22(3):163-8. PubMed ID: 15124181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients.
    Tomás M; Sentí M; García-Faria F; Vila J; Torrents A; Covas M; Marrugat J
    Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2113-9. PubMed ID: 10978257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon.
    Mackness B; Mackness MI; Arrol S; Turkie W; Durrington PN
    Br J Pharmacol; 1997 Sep; 122(2):265-8. PubMed ID: 9313934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia.
    Leus FR; Wittekoek ME; Prins J; Kastelein JJ; Voorbij HA
    Atherosclerosis; 2000 Apr; 149(2):371-7. PubMed ID: 10729387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls.
    Mackness B; Durrington PN; Boulton AJ; Hine D; Mackness MI
    Eur J Clin Invest; 2002 Apr; 32(4):259-64. PubMed ID: 11952811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraoxonase PON1 polymorphism leu-Met54 is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study.
    Schmidt H; Schmidt R; Niederkorn K; Gradert A; Schumacher M; Watzinger N; Hartung HP; Kostner GM
    Stroke; 1998 Oct; 29(10):2043-8. PubMed ID: 9756579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum arylesterase/diazoxonase activity and genetic polymorphisms in patients with type 2 diabetes.
    Inoue M; Suehiro T; Nakamura T; Ikeda Y; Kumon Y; Hashimoto K
    Metabolism; 2000 Nov; 49(11):1400-5. PubMed ID: 11092501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of paraoxonase (PON1) L55M status requires both genotype and phenotype.
    Brophy VH; Jarvik GP; Richter RJ; Rozek LS; Schellenberg GD; Furlong CE
    Pharmacogenetics; 2000 Jul; 10(5):453-60. PubMed ID: 10898114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification.
    Mackness B; Mackness MI; Arrol S; Turkie W; Durrington PN
    FEBS Lett; 1998 Feb; 423(1):57-60. PubMed ID: 9506841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
    Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
    Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum paraoxonase after myocardial infarction.
    Ayub A; Mackness MI; Arrol S; Mackness B; Patel J; Durrington PN
    Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):330-5. PubMed ID: 9974415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?
    Mackness B; Davies GK; Turkie W; Lee E; Roberts DH; Hill E; Roberts C; Durrington PN; Mackness MI
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1451-7. PubMed ID: 11557671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in italian patients.
    Ombres D; Pannitteri G; Montali A; Candeloro A; Seccareccia F; Campagna F; Cantini R; Campa PP; Ricci G; Arca M
    Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1611-6. PubMed ID: 9763534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin-dependent diabetes mellitus.
    Ikeda Y; Suehiro T; Inoue M; Nakauchi Y; Morita T; Arii K; Ito H; Kumon Y; Hashimoto K
    Metabolism; 1998 May; 47(5):598-602. PubMed ID: 9591753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum paraoxonase-1 gene polymorphism and enzyme activity in patients with urolithiasis.
    Atar A; Gedikbasi A; Sonmezay E; Kiraz ZK; Abbasoglu S; Tasci AI; Tugcu V
    Ren Fail; 2016; 38(3):378-82. PubMed ID: 26795139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of PON1 QR 192 and LM 55 polymorphisms with serum paraoxonase activities of Turkish diabetic patients.
    Altuner D; Ates I; Suzen SH; Koc GV; Aral Y; Karakaya A
    Toxicol Ind Health; 2011 Nov; 27(10):873-8. PubMed ID: 21505009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase 1 192 Gln/Arg gene polymorphism and cerebrovascular disease: interaction with type 2 diabetes.
    Koch M; Hering S; Barth C; Ehren M; Enderle MD; Pfohl M
    Exp Clin Endocrinol Diabetes; 2001; 109(3):141-5. PubMed ID: 11409295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The paraoxonase PON1 promoter polymorphism C(-107)T is associated with increased serum glucose concentrations in non-diabetic patients.
    Leviev I; Kalix B; Brulhart Meynet MC; James RW
    Diabetologia; 2001 Sep; 44(9):1177-83. PubMed ID: 11596674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.